Search

everythinglearnresearchcommunity

for

Search:↓

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

Alpha-MSH affects mitochondrial function, and MC1R mutations may increase skin aging.

The gene causing hair loss and heart issues in rough coat mice is still unknown.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Certain gene variations increase the risk of alopecia areata in Koreans.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Changes in NRF2 levels may contribute to hair loss in Egyptian men.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

A gene variant causes patched hair loss in mice, similar to alopecia areata in humans.

Reducing Zyxin may help treat hair loss.

Ritlecitinib works well and is safe for treating alopecia areata.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Mouse models help understand alopecia areata and find treatments.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

AMPK activation may reduce melanoma risk in red-haired individuals.

Rac1 is essential for proper hair structure and color.

Alopecia areata involves specific immune cells, offering potential treatment targets.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.